Login / Signup

Beneficial effects of citrulline enteral administration on sepsis-induced T cell mitochondrial dysfunction.

Florian ReizineMurielle GrégoireMathieu LesouhaitierValentin CoirierJuliette GauthierCéline DelaloyElise DessaugeFlorent CreusatFabrice UhelArnaud GacouinFrédéric DessaugeCécile Le NaouresCaroline MoreauClaude BendavidYoann DanielKilian PetitjeanValérie BordeauClaire LamaisonCaroline PiauVincent CattoirMikael RousselBernard FromentyChristian MicheletYves Le TulzoJaroslaw ZmijewskiRonan ThibaultMichel CognéKarin TarteJean-Marc Tadié
Published in: Proceedings of the National Academy of Sciences of the United States of America (2022)
Severe sepsis induces a sustained immune dysfunction associated with poor clinical behavior. In particular, lymphopenia along with increased lymphocyte apoptosis and decreased lymphocyte proliferation, enhanced circulating regulatory T cells (Treg), and the emergence of myeloid-derived suppressor cells (MDSCs) have all been associated with persistent organ dysfunction, secondary infections, and late mortality. The mechanisms involved in MDSC-mediated T cell dysfunction during sepsis share some features with those described in malignancies such as arginine deprivation. We hypothesized that increasing arginine availability would restore T cell function and decrease sepsis-induced immunosuppression. Using a mouse model of sepsis based on cecal ligation and puncture and secondary pneumonia triggered by methicillin-resistant Staphylococcus aureus inoculation, we demonstrated that citrulline administration was more efficient than arginine in increasing arginine plasma levels and restoring T cell mitochondrial function and proliferation while reducing sepsis-induced Treg and MDSC expansion. Because there is no specific therapeutic strategy to restore immune function after sepsis, we believe that our study provides evidence for developing citrulline-based clinical studies in sepsis.
Keyphrases